Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients

• Marina Chiara Garassino,

  Affiliation Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  ⨯
• Sheila Piva ,

  * E-mail: sheila.piva@fbf.milano.it

  Affiliation Department of Oncology, A.O. Fatebenefratelli & Oftalmico, 23, Milan, Italy

  ⨯
• Nicla La Verde,

  Affiliation Department of Oncology, A.O. Fatebenefratelli & Oftalmico, 23, Milan, Italy

  ⨯
• Ilaria Spagnoletti,

  Affiliation A.O. Sacro Cuore di Gesù, Fatebenefratelli, Benevento, Italy

  ⨯
• Vittorio Iorno,

  Affiliation Policlinico Maggiore, Milan, Italy

  ⨯
• Claudia Carbone,

  Affiliation Department of Oncology Ospedale Serbelloni, Gorgonzola, Italy

  ⨯
• Antonio Febbraro,

  Affiliation A.O. Sacro Cuore di Gesù, Fatebenefratelli, Benevento, Italy

  ⨯
• Anna Bianchi,

  Affiliation Department of Neurology A.O. Sant’Antonio Abate, Gallarate, Italy

  ⨯
• Annalisa Bramati,

  Affiliation Department of Oncology, A.O. Fatebenefratelli & Oftalmico, 23, Milan, Italy

  ⨯
• Anna Moretti,

  Affiliation Department of Oncology, A.O. Fatebenefratelli & Oftalmico, 23, Milan, Italy

  ⨯
• Monica Ganzinelli,

  Affiliation Department of Oncology “Mario Negri” Institute, Milan, Italy

  ⨯
• Mirko Marabese,

  Affiliation Department of Oncology “Mario Negri” Institute, Milan, Italy

  ⨯
• Marta Gentili,

  Affiliation Department of Oncology, A.O. Fatebenefratelli & Oftalmico, 23, Milan, Italy

  ⨯
• Valter Torri,

  Affiliation Department of Oncology “Mario Negri” Institute, Milan, Italy

  ⨯
• Gabriella Farina

  Affiliation Department of Oncology, A.O. Fatebenefratelli & Oftalmico, 23, Milan, Italy

  ⨯